Articles From: Jarden Increases Authorized Share Repurchase Program to $500 Million and Uses $250 Million to Execute an Accelerated Share Repurchase Program to Jazz Pharmaceuticals To Report First Quarter 2013 Financial Results On May 7, 2013


2013/4/24
Record First Quarter Net Sales of $1.58 Billion Net Sales Growth of 5.7% with Organic Net Sales Growth of 4% Adjusted Gross Margin Expansion of 30 basis points RYE, N.Y. , April 24, 2013 /PRNewswire/ -- Jarden Corporation (NYSE:JAH) today reported its financial results for the quarter ended March 31, 2013 .
Sign-up for Jarden Reports First Quarter Results investment picks
2013/2/14
Full Year Operating Cash Flow of $480 million Full Year Gross Margin Expansion of over 70 bps RYE, N.Y. , Feb.
Sign-up for Jarden Reports Record Full Year Results investment picks
2013/5/14
RYE, N.Y. , May 14, 2013 /PRNewswire/ -- Jarden Corporation (NYSE: JAH) today announced that the Company will be presenting at the Barclays High Yield Bond and Syndicated Loan Conference to be held at the JW Marriott Chicago in Chicago, Illinois on Tuesday, May 21, 2013 at 7:30 am Central Daylight Time .
Sign-up for Jarden to Present at Barclays High Yield Bond / Syndicated Loan and Americas Select Franchise Conferences investment picks
2013/5/3
RYE, N.Y. , May 3, 2013 /PRNewswire/ -- Jarden Corporation (NYSE: JAH) today announced that the Company will be presenting at the Baird 2013 Growth Stock Conference to be held at the Four Seasons Hotel in Chicago, Illinois on Tuesday, May 7, 2013 at 10:55 am Central Daylight Time .
Sign-up for Jarden To Present At The Baird 2013 Growth Stock Conference And The Goldman Sachs 2013 Consumer Products Symposium investment picks
2013/5/16
LONDON --
Sign-up for Jardine Strategic: Underlying Earnings Marginally up on Last Year investment picks
2013/5/14
LOS ANGELES , May 14, 2013 /PRNewswire/ -- Global strategic branding firm Siegel+Gale ( www.siegelgale.com ) today announced the promotion of managing director Jason Cieslak to president, Pacific Rim .
Sign-up for Jason Cieslak Promoted to President, Pacific Rim, Siegel+Gale investment picks
2013/2/20
NORFOLK, Va.
Sign-up for Jason Reiner to head Norfolk Southern industrial development; Newell Baker retires investment picks
2013/4/3
Natural Personal Care Leader Launches Facebook Program to Plant Thousands of Trees Worldwide MELVILLE, N.Y. , April 3, 2013 /PRNewswire/ -- A mature, leafy tree produces as much oxygen in one season as ten people inhale in a year[1]. JASON ® brand, a leader in the natural personal care category, is partnering with Earth Day Network's Canopy Project to create enough oxygen to fill thousands of lungs across the globe with a program that will result in the donation of 5,000 new trees to be planted.
Sign-up for JASON® Brand Joins Earth Day Network's Canopy Project, Encourages Consumers To "Like" Their Way To A Greener World investment picks
2013/5/16
PTC (Nasdaq: PMTC) today announced that JATCO, a Nissan subsidiary and global supplier of Automatic Transmissions and Continuously Variable Transmissions (AT/CVT), has selected the PTC Global Software Development solution as the single software engineering platform for its transmission control systems.
Sign-up for JATCO Selects PTC for Global Software Development investment picks
2013/3/29
Java Express, Inc. (OTC BB: JVEX) announces the acquisition of ANEW LIFE, INC., a Utah corporation.
Sign-up for Java Express Acquires ANEW LIFE, INC. investment picks
2013/5/8
VERO BEACH, Fla., May 8, 2013 (GLOBE NEWSWIRE) -- JAVELIN Mortgage Investment Corp.
Sign-up for JAVELIN Mortgage Investment Corp. Announces Pricing of Public Offering of 6,000,000 Shares of Common Stock investment picks
2013/5/7
VERO BEACH, Fla., May 7, 2013 (GLOBE NEWSWIRE) -- JAVELIN Mortgage Investment Corp.
Sign-up for JAVELIN Mortgage Investment Corp. Announces Public Offering of 6,000,000 Shares of Common Stock investment picks
2013/3/19
VERO BEACH, Fla., March 19, 2013 (GLOBE NEWSWIRE) -- JAVELIN Mortgage Investment Corp.
Sign-up for JAVELIN Mortgage Investment Corp. Announces Q2 2013 Monthly Dividend Rate of $0.23 Per Share investment picks
2013/5/6
VERO BEACH, Fla., May 6, 2013 (GLOBE NEWSWIRE) -- JAVELIN Mortgage Investment Corp.
Sign-up for JAVELIN Mortgage Investment Corp. Reports 15.5% Annualized ROE From Taxable REIT Income for the Quarter Ended March 31, 2013 investment picks
2013/3/21
VERO BEACH, Fla., March 21, 2013 (GLOBE NEWSWIRE) -- JAVELIN Mortgage Investment Corp.
Sign-up for JAVELIN Mortgage Investment Corp. Reports 15.8% Annualized ROE From Taxable REIT Income for Initial Operating Period investment picks
2013/4/4
Seattle baseball great Jay Buhner has joined the Frontier Communications (NASDAQ: FTR) lineup as part of a special contest.
Sign-up for Jay Buhner and Frontier Communications Team Up For ‘Baseball with Buhner’ Contest investment picks
2013/4/25
Nutrisystem, Inc. (NASDAQ: NTRI) , a leading provider of weight management products and services, today announced that Jay Herratti has been elected to the Board of Directors, effective immediately.
Sign-up for Jay Herratti Joins Nutrisystem Board of Directors investment picks
2013/5/2
PORTLAND, Ore., May 2, 2013 (GLOBE NEWSWIRE) -- Jay Khetani has been named vice president of Investor Relations for Precision Castparts Corp.
Sign-up for Jay Khetani Named Vice President of Investor Relations for Precision Castparts Corp. investment picks
2013/4/29
Jay Savan has joined Mercer’s Health & Benefits business in Atlanta, where he will serve as a Partner focusing primarily on larger employers.
Sign-up for Jay Savan Joins Mercer’s Atlanta Health & Benefits Business from Towers Watson investment picks
2013/2/22
Historic Tour Will Visit 12 Cities In North America Including New York, Boston, San Francisco, Los Angeles, Chicago, Toronto LOS ANGELES , Feb.
Sign-up for Jay Z And Justin Timberlake Announce LEGENDS OF THE SUMMER Stadium Tour investment picks
2013/5/7
Company Reports Total Revenues of $196 Million Driven by Record Net Sales of Xyrem and Erwinaze Adjusted EPS of $1.37; GAAP EPS of $0.71 Company Announces up to $200 Million Share Repurchase Program DUBLIN , May 7, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter ended March 31, 2013 , updated 2013 financial guidance and key additions to its board of directors.
Sign-up for JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2013 FINANCIAL RESULTS investment picks
2013/2/27
DUBLIN , Feb.
Sign-up for Jazz Pharmaceuticals Announces Participation At Two Investor Conferences In March investment picks
2013/5/13
DUBLIN , May 13, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will participate in three upcoming investor events.
Sign-up for Jazz Pharmaceuticals Announces Participation In Upcoming Investor Events investment picks
2013/3/5
DUBLIN , March 5, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the pricing of a previously announced underwritten public offering of 5,375,000 of its ordinary shares held by certain of its existing shareholders, offered at a price to the public of $58.50 per share.
Sign-up for Jazz Pharmaceuticals Announces Pricing Of Public Offering Of Ordinary Shares By Selling Shareholders investment picks
2013/3/4
DUBLIN , March 4, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced an underwritten public offering of 5,375,000 of its ordinary shares held by certain of its existing shareholders.
Sign-up for Jazz Pharmaceuticals Announces Public Offering Of Ordinary Shares By Selling Shareholders investment picks
2013/2/26
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Concert Pharmaceuticals, Inc. today announced an exclusive license agreement that provides Jazz Pharmaceuticals worldwide rights to develop and commercialize Concert’s deuterium-modified sodium oxybate (D-SXB) compounds, including C-10323.
Sign-up for Jazz Pharmaceuticals plc and Concert Pharmaceuticals Announce Worldwide Licensing Agreement to Develop and Commercialize Deuterium-Modified Sodium Oxybate investment picks
2013/2/26
- Record Total Revenues of $586 Million in 2012 - - Company Provides Guidance for Full Year 2013 Total Revenues of $805 to $835 Million - DUBLIN , Feb.
Sign-up for Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results investment picks
2013/4/23
DUBLIN , April 23, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its first quarter 2013 financial results on Tuesday, May 7, 2013 , after the close of the financial markets.
Sign-up for Jazz Pharmaceuticals To Report First Quarter 2013 Financial Results On May 7, 2013 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Jarden Increases Authorized Share Repurchase Program to $500 Million and Uses $250 Million to Execute an Accelerated Share Repurchase Program to Jazz Pharmaceuticals To Report First Quarter 2013 Financial Results On May 7, 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity